Observational Study of Best Supportive Care With or Without Oral Capecitabine in Patients With Metastatic Gallbladder Carcinoma at a Tertiary Center in India
Compared with BSC alone, patients who receive X + BSC experience an OS improvement of 1.4 months and better pain control without grade 3 toxicities or negative impact on QOL.
Authors
- Shaleen Kumar (ORCID: https://orcid.org/0000-0001-5448-3480)
- Vishwas Kapoor (ORCID: https://orcid.org/0000-0003-0488-3720)
- Shagun Misra (ORCID: https://orcid.org/0000-0003-3196-5094)
- Neeraj Rastogi (ORCID: https://orcid.org/0009-0001-2168-7134)
- Abhinav Srivastava
Institutions
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1200/go-24-00341
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00